US Coverage
Law360 | The Practice of Law
State Specific Coverage
Law360 Authority | Deep News & Analysis
February 19, 2025
Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al.
Case Number:
24-889
Court:
Nature of Suit:
830 Patent Infringement (Fed. Qst.)
Firms
- Ashurst Perkins
- Barnes & Thornburg
- Covington & Burling
- Dinsmore & Shohl
- Foley Hoag
- Goodwin Procter
- Jenner & Block
- Jones Day
- Massey & Gail
- McDonnell Boehnen
- Orrick Herrington
- Upadhye Tang
- Weil Gotshal
- Winston Taylor
- Zuckerman Spaeder
Companies
- AbbVie Inc.
- American Intellectual Property Law Association
- Association for Accessible Medicines
- Hikma Pharmaceuticals PLC
- Intellectual Property Owners Association
- Pharmaceutical Research & Manufacturers of America
- Public Citizen Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 08, 2026
Biggest Rulings For Patent Attys In 2026: A Midyear Report
The U.S. Supreme Court clarified the pleading standard for induced infringement of skinny labels, and the Federal Circuit opened the door to increased damages for patent owners. Here's what you need to know about these patent cases and other major decisions from the beginning of 2026.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login